Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pulmonary Hypertension
100%
Prognostic Marker
100%
Red Cell Distribution Width
100%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
100%
Blood Urea Nitrogen
66%
Confidence Interval
33%
Hazard Ratio
33%
Urea-N
33%
Right-sided
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Pulmonary Arterial Hypertension
16%
Prognostic Utility
16%
Mortality Prediction
16%
Phosphodiesterase Inhibitors
16%
Hemoglobin
16%
Clinical Laboratory
16%
Cardiac Patients
16%
Cardiac Catheterization
16%
Adverse Outcomes
16%
Cox Proportional Hazards Model
16%
Consecutive Patients
16%
Univariate Analysis
16%
Clinical Variables
16%
Connective Tissue Disease
16%
Laboratory Data
16%
Multivariate Model
16%
Mean Corpuscular Volume
16%
Demographic Variables
16%
Hemodynamic Parameters
16%
Laboratory Parameters
16%
Mean Pulmonary Artery Pressure (mPAP)
16%
Prognostic Indicator
16%
Severe Pulmonary Hypertension
16%
Left-sided Heart Failure
16%
Vital Status
16%
Diuretic Use
16%
Medicine and Dentistry
Pulmonary Hypertension
100%
Amino Terminal Sequence
100%
Brain Natriuretic Peptide
100%
Blood Urea Nitrogen
66%
Hazard Ratio
33%
Biological Marker
16%
Prospective Study
16%
Hemodynamic
16%
Diabetes Mellitus
16%
Phosphodiesterase Inhibitor
16%
Congestive Heart Failure
16%
Adverse Outcome
16%
Proportional Hazards Model
16%
Univariate Analysis
16%
Lung Artery Pressure
16%
Connective Tissue Disease
16%
Mean Corpuscular Volume
16%
Cardiac Catheterization
16%
Red Blood Cell Distribution Width
16%
Diuretics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Brain Natriuretic Peptide
100%
Ureaplasma
66%
Prospective Study
16%
Biological Marker
16%
Congestive Heart Failure
16%
Adverse Outcome
16%
Diabetes Mellitus
16%
Phosphodiesterase Inhibitor
16%
Connective Tissue Disease
16%
Diuretics
16%